ConductScience.org, home

Trial · NCT06432309

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

NCT06432309, Not applicable, Completed, University Hospital of Ferrara

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease. Trials, record NCT06432309. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06432309

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
NCT number
NCT06432309
Status
Completed
Phases
Not applicable
Enrollment
22 participants, actual
Lead sponsor
University Hospital of Ferrara
Conditions
Parkinson Disease, Effect of Drug
Interventions
Opicapone 50 mg, Duodopa
First posted
2024-05-29
Last updated
2025-03-03

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryEvaluation of motor fluctuations changes12 monthsChanges in MDS-UPDRS part IV from the initial assessment to 12 months follow-up.
PrimaryEvaluation of dyskinesia changes12 monthsChanges in UDysRS from the initial assessment to 12 months follow-up.
SecondaryChanges in non-motor aspects of patients' daily living experiences12 monthsChanges of MDS-UPDRS I score from the initial assessment to 12 months follow-up.
SecondaryChanges in motor aspects of patients' daily living experiences12 monthsChanges of of MDS-UPDRS II score from the initial assessment to 12 months follow-up.
SecondaryChanges in non-motor symptoms in Parkinson's disease-cognition12 monthsChanges of MOCA score from the initial assessment to 12 months follow-up.
SecondaryNeurophysiological outcome12 monthsChanges of sural amplitude potential through electroneurography from the initial assessment to 12 months follow-up.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
30264443BACKGROUNDPubMed
32597817RESULTPubMed
35785401BACKGROUNDPubMed
38287715BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06432309

GET https://conductscience.org/api/trials/v1/NCT06432309/registered